Cargando…

Virtual reality for the assessment and rehabilitation of neglect: where are we now? A 6-year review update

Unilateral spatial neglect (USN) is a frequent repercussion of a cerebrovascular accident, typically a stroke. USN patients fail to orient their attention to the contralesional side to detect auditory, visual, and somatosensory stimuli, as well as to collect and purposely use this information. Tradi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavedoni, S., Cipresso, P., Mancuso, V., Bruni, F., Pedroli, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148943/ https://www.ncbi.nlm.nih.gov/pubmed/35669614 http://dx.doi.org/10.1007/s10055-022-00648-0

Ejemplares similares

Virtual Reality Meets Non-invasive Brain Stimulation: Integrating Two Methods for Cognitive Rehabilitation of Mild Cognitive Impairment
por: Mancuso, Valentina, et al.
Publicado: (2020)

Assessment and rehabilitation of neglect using virtual reality: a systematic review
por: Pedroli, Elisa, et al.
Publicado: (2015)

Transcranial Magnetic Stimulation Meets Virtual Reality: The Potential of Integrating Brain Stimulation With a Simulative Technology for Food Addiction
por: Stramba-Badiale, Chiara, et al.
Publicado: (2020)

Digital Biomarkers for the Early Detection of Mild Cognitive Impairment: Artificial Intelligence Meets Virtual Reality
por: Cavedoni, Silvia, et al.
Publicado: (2020)

Using Virtual Reality to Rehabilitate Neglect
por: Sedda, A., et al.
Publicado: (2013)

One year update on the COVID-19 pandemic: Where are we now?
por: Mishra, Sanjay Kumar, et al.
Publicado: (2021)

Virtual Reality as a Possible Tool for the Assessment of Self-Awareness
por: Muratore, Manuel, et al.
Publicado: (2019)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Cognition Meets Gait: Where and How Mind and Body Weave Each Other in a Computational Psychometrics Approach in Aging
por: Bruni, Francesca, et al.
Publicado: (2022)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

The impact of ICCPR's Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go?
por: Turk-Adawi, Karam, et al.
Publicado: (2023)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
por: Park, Sang Hyoung
Publicado: (2022)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Virtual multiple errands test (VMET): a virtual reality-based tool to detect early executive functions deficit in Parkinson’s disease
por: Cipresso, Pietro, et al.
Publicado: (2014)

Disentangling the Contribution of Spatial Reference Frames to Executive Functioning in Healthy and Pathological Aging: An Experimental Study with Virtual Reality
por: Serino, Silvia, et al.
Publicado: (2018)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

A Psychometric Tool for a Virtual Reality Rehabilitation Approach for Dyslexia
por: Pedroli, Elisa, et al.
Publicado: (2017)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Mindfulness in psychiatry – where are we now?
por: Groves, Paramabandhu
Publicado: (2016)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Pegfilgrastim Biosimilars: Where Are We Now?
por: Selby, Christopher, et al.
Publicado: (2021)

Hepatocellular adenoma: Where are we now?
por: Wang, Xi, et al.
Publicado: (2022)

Osteopontin and Transplantation: Where Are We Now?
por: Kaleta, Beata
Publicado: (2021)

Epilepsy and psychosis– where are we now?
por: Pereira, I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bsq82findgqitcd13d2johlvet